Delivery Order SPE2DB20D1109-SPE2DB25FP18U

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a firm fixed price of $1,599.24 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of XELJANZ XR 11 MG TABLET, a pharmaceutical product, with a performance period through May 21, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $6,758.90 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through March 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,552.82 delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty medication. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $6,717.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.56 firm fixed-price contract is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,685.54 firm fixed-price contract is for the supply of XELJANZ XR 11 MG TABLET, a pharmaceutical product, with a period of performance through May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $61,183.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The award is a delivery order contract for the supply of XELJANZ XR 11 MG TABLET, a medication used to treat certain autoimmune conditions. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $17,247.01 for the supply of XELJANZ XR 11 MG TABLET. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 2, 2023. The contract is a firm fixed price type and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,758.13 fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,345.58 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, with an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP18U
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $1,873.25 and a ceiling value of $1,873.25. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through June 6, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/4/25, 10:03 AM